Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Adenocarcinoma
Interventions: DRUG: BIWA 4
Sponsor: Boehringer Ingelheim